Reducing Appeal Turnaround Times in Independent Medical Review: A Physician’s Case Study on Documentation Quality, Process Integrity, and the Role of Specialized IRO Services
Prepared by: Stephen Keresztes, M.D.
May 2026
Abstract
The independent medical review industry faces a persistent and consequential challenge: appeal turnaround times that fall short of both regulatory expectations and patient needs. In this case study, I draw on my direct experience as a physician in independent medical review to examine the systemic and documentation-level factors that drive delays across both internal and external appeal resolution processes. I present a clinical framework for improvement grounded in documentation rigor, process discipline, and specialized reviewer expertise, illustrated through the operational model of medlitix (www.medlitix.org).
1. Introduction
Independent Review Organizations (IROs) occupy a critical position in the healthcare ecosystem. As defined by the National Association of Independent Review Organizations (NAIRO), an IRO acts as a third-party medical review resource providing objective, unbiased determinations based solely on medical evidence, delivering conflict-free decisions that help clinical and claims management professionals allocate healthcare resources appropriately and resolve utilization disputes with integrity.
The demand for these services continues to grow as healthcare claims become more complex, regulatory mandates expand, and payers, including medical insurance companies, third-party administrators (TPAs), health maintenance organizations (HMOs), and self-insured entities, increasingly rely on both internal clinical review teams and external clinical expertise for defensible determinations. The Department of Labor’s Employee Benefits Security Administration (EBSA) oversees health plans covering 153 million workers, retirees, and dependents. CMS data shows that ACA Marketplace insurers denied approximately 20% of in-network claims in 2024, generating a substantial and growing volume of internal and external appeals that IROs and health plan review teams are called upon to resolve.
Yet a fundamental tension remains: the pressure to deliver faster appeal decisions is in direct conflict with the clinical thoroughness those decisions require. This tension is present at every stage of the process, from the internal appeal conducted by the health plan to the external review performed by an independent organization. Documentation deficiencies, process misalignments, and inadequate reviewer matching consistently delay resolution and compromise outcomes for all parties.
2. The Regulatory Framework Governing Turnaround Times
The Utilization Review Accreditation Commission (URAC) is the principal accrediting body for IROs in the United States. URAC accreditation requires that IROs establish reviewer qualifications, maintain freedom from conflicts of interest, address medical necessity with clinical precision, and adhere to reasonable timeframes for both standard and expedited reviews. At the internal review level, the ACA and ERISA similarly require health plans to provide claimants with timely decisions, generally within 30 days for pre-service claims and 60 days for post-service claims, establishing a parallel set of obligations that govern the first layer of the appeal process. URAC works collaboratively with NAIRO, a membership organization comprising more than 30 of the nation’s most established IROs, to track legislative developments, advance accreditation standards, and assess emerging trends across the industry.
Federally, the ACA mandates that IROs render decisions on standard external reviews within 45 days of receipt of a complete request, and within 72 hours for expedited external reviews. NAIRO has formally stated that 24- to 48-hour expedited review timeframes should be reserved exclusively for life-threatening clinical situations, a position grounded in a clinically sound principle: speed in isolation is not a quality metric.
The 2024 Independent Medical Review Report for California illustrates what is achievable under a well-structured program. The state’s Independent Medical Review Organization (IMRO) issued 141,621 final determinations in 2024, an 8.29% increase over the prior year, with an average time from receipt of all medical records to final determination of just six to seven days. Notably, 74% of those determinations were rendered by reviewers holding board certification in a directly relevant specialty, underscoring the relationship between specialty matching and both quality and efficiency.
3. Case Study: Root Causes of Delay in Independent Medical Review
In my experience conducting and reviewing independent medical determinations, I have identified a consistent set of factors that account for the majority of avoidable delays in both internal and external appeal turnaround times. These are not failures unique to any single organization, they are industry-wide patterns with identifiable causes and correctable solutions.
3.1 Incomplete Medical Documentation
The most prevalent cause of delay is the submission of incomplete medical records. As NAIRO has noted in published guidance, IROs are frequently confronted with critical documentation not available within the electronic medical record. This problem is equally present at the internal review stage: health plan medical directors and internal reviewers face the same evidentiary gaps, which drive incomplete initial determinations and fuel downstream appeals. When a reviewer, internal or external, must interrupt its review to track down missing records, the clock continues while an accurate clinical determination remains impossible.
Cases missing operative reports, psychiatric evaluations, imaging results, and laboratory findings essential to establishing causation or medical necessity cause delays. A determination rendered without those records is clinically indefensible, yet statutory deadlines do not pause for incomplete submissions. As one senior reviewer cited in NAIRO literature observed, “there are pitfalls to doing appeals too fast.” A fast turnaround on an incomplete record is not a turnaround, it is a liability.
3.2 Inappropriate Reviewer Assignment
The second major driver of delay is the mismatch between a reviewer’s specialty and the condition under review. URAC standards require that clinical reviewers, hold current licensure, maintain recent familiarity with applicable clinical knowledge, and possess at least five years of relevant experience. The standard is deliberately high: a reviewer working outside their area of expertise must spend disproportionate time in preparation, is more likely to request additional information, and may produce a determination that is challenged on credibility grounds.
3.3 Absence of Literature-Based Clinical Rationale
A third pattern involves the submission of physician opinions lacking grounding in the most current evidence-based medical literature. When a treating physician submits a clinical opinion without citing the most recent peer-reviewed evidence, the IRO reviewer must independently construct the evidentiary foundation, adding time, interpretive risk, and the potential for additional consultation. This gap is equally consequential at the internal review stage, where health plan medical directors making initial determinations are held to the same evidentiary standards and face the same exposure when current literature is absent from the record. A well-constructed, literature-supported opinion submitted with an appeal accelerates review by providing the reviewing physician with a clear, documented framework. A generic or conclusory opinion forces the reviewer to build the clinical rationale from the ground up.
3.4 Structural Process Misalignments
Beyond clinical documentation, structural factors contribute materially to delay across both internal and external review processes: jurisdictional variation in expedited review timeframes; inconsistency in how carriers, TPAs, and providers transmit records; and administrative systems that bypass established IRO assignment protocols. At the internal level, fragmented handoffs between claims operations and medical management teams introduce additional friction that compounds downstream. NAIRO has actively engaged with state regulatory bodies on these process challenges, correctly recognizing that systemic delay rarely has a single cause, it emerges from the compounding of multiple inefficiencies across the review chain.
4. The medlitix Model: Applying IRO Principles in Practice
The operational approach developed by medlitix (www.medlitix.org) is a direct clinical response to the delay patterns described above, built on five principles that address each root cause applicable to both internal and external review contexts.
Complete Records Review as a Precondition. Every engagement begins with a thorough review of all available clinical records before the formal opinion process begins. Requests for additional documentation are identified and resolved immediately at the outset.
Board-Certified, Specialty-Matched Physicians. Every opinion produced through medlitix is completed by a Board-Certified physician whose specialty is directly relevant to the condition under review. A board-certified specialist reviewing within their area of active practice moves through the evidentiary record with a precision and efficiency that a generalist reviewer cannot replicate.
Most Current Evidence-Based Literature as Standard Practice. Every medlitix opinion is grounded in the most current, peer-reviewed evidence-based medical literature available at the time of review. Rather than relying solely on clinical judgment which, while valuable, is subject to challenge, each opinion explicitly references the most recent published evidence base. This produces opinions that are defensible, transparent, and aligned with the evidentiary standards required by URAC-accredited review processes, while reducing the likelihood of re-review or appeal.99.9% On-Time Delivery – A Verified Performance Standard. medlitix achieves a 99.9% on-time delivery rate from receipt of a complete case file to delivery of a final opinion — a performance standard that distinguishes medlitix from the broader IRO market. This rate is tracked, verified, and reported across all standard and expedited review types, for both internal advisory opinions and external independent determinations. It is conditioned on file completeness, consistent with NAIRO’s guidance.
5. Recommendations and Conclusion
The following recommendations emerge from this analysis for IROs, payers, health plans, and clinical administrators engaged in both internal and external appeal processes:
Invest upstream in documentation quality. The most effective way to reduce appeal turnaround times is to improve the completeness of documentation submitted at the outset. Clear submission standards and structured physician guidance on what constitutes a complete, reviewable record are essential. medlitix has advanced this principle further through the deployment of agentic AI, which autonomously reviews incoming case files for completeness, flags missing records, and initiates retrieval requests before the clinical reviewer ever opens the file. What historically required hours of administrative triage is now completed in minutes, compressing upstream intake time to a fraction of its former duration and enabling physician reviewers to begin substantive clinical analysis enabling physician reviewers to begin substantive clinical analysis significantly sooner.
Enforce specialty matching as a clinical standard. Reviewer assignment must be treated as a non-negotiable quality requirement, not an administrative convenience. IROs should invest in the reviewer networks necessary to support specialty matching across the full range of clinical conditions under review.
Require the most current evidence-based literature. Organizations that accept clinical opinions without grounding in the most current peer-reviewed evidence are accepting documents that will take longer to review, generate more information requests, and are less likely to produce determinations that withstand scrutiny at either the internal or external review stage.
Adopt an integrated quality framework. Taken together, investing in documentation completeness, enforcing specialty matching, requiring the most current evidence-based literature, achieving a verified 99.9% on-time delivery rate, and leveraging purpose-built agentic AI do not reduce turnaround times in isolation, they compound. Complete records eliminate the most common source of delay. Specialty-matched reviewers move through the clinical record with precision and speed. Literature grounded in the most current evidence reduces re-review rates and the likelihood of successful challenge. A verified 99.9% on-time delivery standard creates accountability that drives every upstream process. And agentic AI at the intake stage compresses the time before clinical review even begins, transforming a historically manual and error-prone process into one that is systematic, auditable, and fast. These principles apply equally whether the determination is an internal health plan review or an external independent opinion, the clinical and operational disciplines that produce quality are the same. The organizations that achieve the shortest turnaround times with the most defensible outcomes are those that treat each of these elements as interdependent, not optional, and build their operational model accordingly.
The challenge of reducing appeal turnaround times is not primarily a technology or staffing problem, it is a documentation quality and process discipline problem. When clinical records are complete, reviewer assignments are specialty-matched, and supporting opinions are grounded in the most current evidence-based literature, turnaround times compress naturally and outcomes improve for all parties at both the internal and external review stage.
medlitix (www.medlitix.org) was founded on that commitment, and its operational model represents a practical application of the principles this case study has outlined. The organizations that will lead the independent medical review industry forward are those that solve not just for faster, but for better, delivering the highest standard of clinical quality and the most defensible reviews in the industry.
Contact: Steve Keresztes, MD
skeresztes@mlxiro.com | +1 724-284-8797 | www.medlitix.org
PROFESSIONAL | ACCURATE | EVIDENCE-DRIVEN
© 2026 medlitix. All rights reserved. This white paper represents the independent clinical perspective of the author and is intended for informational and educational purposes within the healthcare and independent medical review industries. It does not constitute legal, regulatory, or clinical advice applicable to any specific case or circumstance.